Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053839596> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2053839596 endingPage "372" @default.
- W2053839596 startingPage "363" @default.
- W2053839596 abstract "This open-label multicenter study evaluated the long-term safety and efficacy of intrathecal ziconotide and included 78 patients with chronic pain who had completed one of two previous ziconotide clinical trials. Each patient's initial ziconotide dose was based on his or her dose from the study of origin and was adjusted as necessary on the basis of adverse events and analgesic effect. The median ziconotide dose was 6.48 mcg/day (range, 0.00-120.00 mcg/day) at the Initial Visit and ranged from 5.52 to 7.20 mcg/day across all study visits. The most commonly reported new adverse events that were considered ziconotide related were memory impairment (11.3%); dizziness, nystagmus, and speech disorder (8.5% each); nervousness and somnolence (7.0% each); and abnormal gait (5.6%). There was no evidence of increased adverse event incidence at higher cumulative ziconotide doses. Elevations in creatine kinase were noted, but the proportion of patients with creatine kinase elevations did not change from the Initial Visit to the Termination Visit (4.1% each). Stable mean Visual Analog Scale of Pain Intensity scores during the three years of the study suggested no evidence of increased pain intensity with increased duration of ziconotide exposure. Long-term treatment with ziconotide appeared to be well tolerated and effective in patients whose response to ziconotide and ability to tolerate the drug had been previously demonstrated." @default.
- W2053839596 created "2016-06-24" @default.
- W2053839596 creator A5020419303 @default.
- W2053839596 creator A5045020425 @default.
- W2053839596 creator A5063350194 @default.
- W2053839596 creator A5078631603 @default.
- W2053839596 date "2009-03-01" @default.
- W2053839596 modified "2023-10-14" @default.
- W2053839596 title "Long-Term Intrathecal Ziconotide for Chronic Pain: An Open-Label Study" @default.
- W2053839596 cites W1560119701 @default.
- W2053839596 cites W1594133400 @default.
- W2053839596 cites W1655589213 @default.
- W2053839596 cites W1966951820 @default.
- W2053839596 cites W1990237430 @default.
- W2053839596 cites W2005193809 @default.
- W2053839596 cites W2037378018 @default.
- W2053839596 cites W2071003827 @default.
- W2053839596 cites W2092424786 @default.
- W2053839596 cites W2106109388 @default.
- W2053839596 cites W2139489105 @default.
- W2053839596 cites W2151024126 @default.
- W2053839596 cites W2161344815 @default.
- W2053839596 cites W2171682691 @default.
- W2053839596 cites W2915405327 @default.
- W2053839596 doi "https://doi.org/10.1016/j.jpainsymman.2008.02.016" @default.
- W2053839596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18715748" @default.
- W2053839596 hasPublicationYear "2009" @default.
- W2053839596 type Work @default.
- W2053839596 sameAs 2053839596 @default.
- W2053839596 citedByCount "57" @default.
- W2053839596 countsByYear W20538395962012 @default.
- W2053839596 countsByYear W20538395962013 @default.
- W2053839596 countsByYear W20538395962014 @default.
- W2053839596 countsByYear W20538395962015 @default.
- W2053839596 countsByYear W20538395962016 @default.
- W2053839596 countsByYear W20538395962017 @default.
- W2053839596 countsByYear W20538395962018 @default.
- W2053839596 countsByYear W20538395962019 @default.
- W2053839596 countsByYear W20538395962021 @default.
- W2053839596 countsByYear W20538395962022 @default.
- W2053839596 countsByYear W20538395962023 @default.
- W2053839596 crossrefType "journal-article" @default.
- W2053839596 hasAuthorship W2053839596A5020419303 @default.
- W2053839596 hasAuthorship W2053839596A5045020425 @default.
- W2053839596 hasAuthorship W2053839596A5063350194 @default.
- W2053839596 hasAuthorship W2053839596A5078631603 @default.
- W2053839596 hasBestOaLocation W20538395961 @default.
- W2053839596 hasConcept C126322002 @default.
- W2053839596 hasConcept C14184104 @default.
- W2053839596 hasConcept C157820659 @default.
- W2053839596 hasConcept C1862650 @default.
- W2053839596 hasConcept C197934379 @default.
- W2053839596 hasConcept C2779034229 @default.
- W2053839596 hasConcept C2780820201 @default.
- W2053839596 hasConcept C2781118164 @default.
- W2053839596 hasConcept C36880943 @default.
- W2053839596 hasConcept C42219234 @default.
- W2053839596 hasConcept C71924100 @default.
- W2053839596 hasConceptScore W2053839596C126322002 @default.
- W2053839596 hasConceptScore W2053839596C14184104 @default.
- W2053839596 hasConceptScore W2053839596C157820659 @default.
- W2053839596 hasConceptScore W2053839596C1862650 @default.
- W2053839596 hasConceptScore W2053839596C197934379 @default.
- W2053839596 hasConceptScore W2053839596C2779034229 @default.
- W2053839596 hasConceptScore W2053839596C2780820201 @default.
- W2053839596 hasConceptScore W2053839596C2781118164 @default.
- W2053839596 hasConceptScore W2053839596C36880943 @default.
- W2053839596 hasConceptScore W2053839596C42219234 @default.
- W2053839596 hasConceptScore W2053839596C71924100 @default.
- W2053839596 hasIssue "3" @default.
- W2053839596 hasLocation W20538395961 @default.
- W2053839596 hasLocation W20538395962 @default.
- W2053839596 hasOpenAccess W2053839596 @default.
- W2053839596 hasPrimaryLocation W20538395961 @default.
- W2053839596 hasRelatedWork W1914878879 @default.
- W2053839596 hasRelatedWork W2000217995 @default.
- W2053839596 hasRelatedWork W2021085111 @default.
- W2053839596 hasRelatedWork W2050786902 @default.
- W2053839596 hasRelatedWork W2102018567 @default.
- W2053839596 hasRelatedWork W2153954868 @default.
- W2053839596 hasRelatedWork W2376917032 @default.
- W2053839596 hasRelatedWork W2580729576 @default.
- W2053839596 hasRelatedWork W4248047185 @default.
- W2053839596 hasRelatedWork W4382810264 @default.
- W2053839596 hasVolume "37" @default.
- W2053839596 isParatext "false" @default.
- W2053839596 isRetracted "false" @default.
- W2053839596 magId "2053839596" @default.
- W2053839596 workType "article" @default.